# Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

> **NCT04952480** · PHASE2 · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 31 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **RADIATION:** Dose-escalated adaptive radiotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT04952480
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-13
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04952480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04952480, "Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04952480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*